|
 |
 |
 |
 |
 |
 |
Treatments
Treatments for GIST
Patients with GIST cancer can be treated effectively today.
Current Treatments
- Surgery - Surgery is the first step in treating GIST and is often curative.
- Imatinib (Gleevec) - Imatinib (Gleevec) is FDA-approved for unresectable and metastatic GIST.
- Sunitinib (Sutent) - Sunitinib (Sutent) is FDA-approved for GIST resistant to imatinib/Gleevec and for patients who are intolerant of imatinib/Gleevec.
- Hepatic artery embolization - Embolization is a surgical procedure for liver metastases of GIST.
- Radiofrequency ablation - RFA is a surgical procedure for liver metastases of GIST.
- Current Treatment Directions - overview and list of consensus documents
GIST Patients' Right to Treatment - the Bad Nauheim Declaration, endorsed by GIST Support International, for the right of all GIST cancer patients to receive up-to-date treatment.
Emerging Treatments
- Emerging Treatments covers drugs in pre-clinical development and in clinical trials.
Clinical Trials
- Clinical Trials informs you about current trials for gastrointestinal stromal tumor plus things to consider before signing up for a trial. This page includes a table showing all clinical trials for GIST, plus maps of locations of trials for GIST cancer.
